The IRS can, and likely, will continue subsidies for HealthCare.gov customers temporarily if the Supreme Court says they're illegal, a tax expert says.» Read More
The Obama administration plans on releasing online tools and other resources to help people deal with the tax implications of Obamacare.
Biogen Idec's anti-LINGO-1, showed promise in a mid-stage study in reversing the nerve damage associated with acute optic neuritis.
A new study shows that even as job-based health insurance prices slow, workers are paying a bigger share of the costs.
There are strategies biz owners can take besides enrolling in a health exchange. Among them: partner with a primary-care provider.
Seven Californians and two people in Utah have measles likely contracted on trips last month to Disney theme parks in California, officials said.
A new family of powerful antibiotics may provide a weapon against the growing threat of drug-resistant superbugs. NBC News reports.
Enrollment has dramatically slowed on the federal Obamacare exchange since before the Christmas holiday
Premiums for Harvard's employee health plan will drop even as the Ivy League school imposes deductibles and co-insurance for the first time.
This year’s flu season is shaping up to be as bad as expected. That's good news for drug stores, but insurers and others could suffer.
The percentage of people lacking health insurance has reached new lows amid Obamacare's ongoing sign-up season.
Various factors, including a lack of coverage or whether or not a plan is subsidized, can affect an individual's refund total.
Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic.
The Justice Department is joining two lawsuits against a Florida cardiologist, according to the Dow Jones News Service.
A new drug activates receptors in the intestine, tricking the body into thinking it has just eaten a meal.
Gilead Sciences' hepatitis C drugs, Sovaldi and Harvoni, will get exclusive coverage on several plans from CVS/Caremark.
Although many Harvard experts advised on health care reform, university faculty are now up in arms over rising prices, the NYT reports.
Despite drug pricing concerns that weighed on Gilead Sciences' stock toward the end of December, the drugmaker started the year by raising prices.
Rather than pay so much out-of-pocket, many skip checkups and scrimp on care, USA Today reports.
Binge drinkers beware: that hangover reveals only a fraction of the physical damage you will weather.
New Year's Eve is one of the biggest nights of the year for champagne sales. New Year's Day is one of the biggest days of the year for hangover cures.
Get the best of CNBC in your inbox